4//SEC Filing
KEEGAN JOSEPH D 4
Accession 0000914190-21-000397
CIK 0000842023other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 4:37 PM ET
Size
11.6 KB
Accession
0000914190-21-000397
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
KEEGAN JOSEPH D
Director
Transactions
- Award
Stock Option (right to buy)
2021-10-28+633→ 633 totalExercise: $515.24Exp: 2031-10-28→ Common Stock (633 underlying) - Award
Common Stock
2021-10-28+194→ 2,333 total
Holdings
- 1,898
Stock Option (right to buy)
Exercise: $179.84From: 2019-10-24Exp: 2028-10-25→ Common Stock (1,898 underlying) - 3,125
Stock Option (right to buy)
Exercise: $125.05From: 2018-10-25Exp: 2027-10-26→ Common Stock (3,125 underlying) - 2,011
Stock Option (right to buy)
Exercise: $201.64From: 2020-10-24Exp: 2029-10-24→ Common Stock (2,011 underlying) - 1,507
Stock Option (right to buy)
Exercise: $255.69From: 2021-10-28Exp: 2030-10-29→ Common Stock (1,507 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of the one year anniversary of the grant date (10/28/21) or the date of Bio-Techne's 2022 annual meeting of shareholders.
Documents
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001260556
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 4:37 PM ET
- Size
- 11.6 KB